FIGURE 6-1 Strengths, weaknesses, opportunities, and threats for the NEWMEDS initiative.
NOTE: EFPIA = Federation of European Pharmaceutical Industries and Associations.
SOURCE: Steckler presentation, March 29, 2012.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement